Chronic obstructive pulmonary disease in patients under age 65: Utilization and costs from a managed care sample

Journal of Occupational and Environmental Medicine

Volumn 47, Issue 11, 2005, Pages 1125-1130

  Tinkelman, David G ^a   George, Dorothy ^b   Halbert, R J ^b,c  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b Cerner Health Insights   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; COST OF ILLNESS; EMERGENCY HEALTH SERVICE; FEMALE; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; PREVALENCE; SCORING SYSTEM; UNITED STATES;

EID: 27844474685     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jom.0000184876.95011.23     Document Type: Article

References (21)

1. Adams PF, Hendershot GE, Marano MA. Current estimates from the National Health Interview Survey, 1996. National Center for Health Statistics. Vital Health Stat. 1999;10.
2. Kesten S. Chronic obstructive pulmonary disease in a managed care setting. Dis Manage Health Outcomes. 2001;9:589-599.
3. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ. 2002;51:1-16.
4. Rennard S, Decramer M, Calverley PM, et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J. 2002;20:799-805.
5. Sin DD, Stafinski T, Ng YC, Bell NR, Jacobs P. The impact of chronic obstructive pulmonary disease on work loss in the United States. Am J Respir Crit Care Med. 2002;165:704-707.
6. Tinkelman D, Corsello P. Chronic obstructive pulmonary disease: the impact occurs earlier than we think. Am J Manag Care. 2003;9:767-771.
7. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2000;160:1683-1689.
8. Eisner MD, Yelin EH, Trupin L, Blanc PD. The influence of chronic respiratory conditions on health status and work disability. Am J Public Health. 2002;92:1506-1513.
9. Leigh JP, Romano PS, Schenker MB, Kreiss K. Costs of occupational COPD and asthma. Chest. 2002;121:264-272.
10. Mapel DW, Hurley JS, Frost FJ, Petersen HV, Picchi MA, Coultas DB. Health care utilization in chronic obstructive pulmonary disease: a case-control study in a health maintenance organization. Arch Intern Med. 2000;160:2653-2658.
11. Strassels SA, Smith DH, Sullivan SD, Mahajan PS. The costs of treating COPD in the United States. Chest. 2001;119:344-352.
12. Ward MM, Javitz HS, Smith WM, Whan MA. Lost income and work limitations in persons with chronic respiratory disorders. J Clin Epidemiol. 2002;55:260-268.
13. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol. 2001;107:3-8.
14. Balmes RJ. Occupational contribution to the burden of chronic obstructive pulmonary disease. J Occup Environ Med. 2004;47:154-160.
15. Deyo RA, Gherkin DC, Ciol MA. Adapting a clnical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
16. Mannino DM. Epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest. 2002;121(suppl):121S-126S.
17. Marklund B, Tunsater A, Bengtsson C. How often is the diagnosis of bronchial asthma correct? Fam Pract. 1999;16:112-116.
18. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: NHLBI/WHO Workshop Report. Updated 2004. Available at: www. goldcopd.com.
19. Friedman M, Hilleman DE. Economic burden of chronic obstructive pulmonary disease: impact of new treatment options. Pharmacoeconomics. 2001;19:245-254.
20. Hilleman DE, Dewan N, Malesker M, Friedman M. Pharmacoeconomic evaluation of COPD. Chest. 2000;118:1278-1285.
21. Birnbaum HG, Morley M, Greenberg PE, Colice GL. Economic burden of respiratory infections in an employed population. Chest. 2002;122:603-611.